Kintsugi Therapeutics
Kintsugi Therapeutics is a biopharmaceutical company that develops innovative therapies.
Kintsugi Therapeutics is active in the biotechnology, medical, pharmaceutical space based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2019.
Within the biotechnology, medical, pharmaceutical space, the company focuses on its core offering rather than a broad product line.
Its base of operations is European Union (EU), Europe, Middle East, and Africa (EMEA).
It is recorded at the Seed stage.
Its team size is recorded as c_00001_00010 employees.
Public records show total funding of about $986K.
| Sector | Biotechnology, Medical, Pharmaceutical |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2019 |
| Employees | c_00001_00010 |
| Stage | seed |
| Total funding | $986,000 |
Website: kintsugitx.com/es
Sign in to view the contact information we hold for Kintsugi Therapeutics.
Create a free account
Create a free account